rs56064803

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1

The NM_021072.4(HCN1):​c.201_209delTGGCGGCGG​(p.Gly68_Gly70del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,529,748 control chromosomes in the GnomAD database, including 621 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G67G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.028 ( 87 hom., cov: 32)
Exomes 𝑓: 0.020 ( 534 hom. )

Consequence

HCN1
NM_021072.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.38

Publications

3 publications found
Variant links:
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
HCN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 24
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • generalized epilepsy with febrile seizures plus, type 10
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_021072.4.
BP6
Variant 5-45695884-GCCGCCGCCA-G is Benign according to our data. Variant chr5-45695884-GCCGCCGCCA-G is described in ClinVar as Benign. ClinVar VariationId is 95999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0599 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCN1NM_021072.4 linkc.201_209delTGGCGGCGG p.Gly68_Gly70del disruptive_inframe_deletion Exon 1 of 8 ENST00000303230.6 NP_066550.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCN1ENST00000303230.6 linkc.201_209delTGGCGGCGG p.Gly68_Gly70del disruptive_inframe_deletion Exon 1 of 8 1 NM_021072.4 ENSP00000307342.4
HCN1ENST00000673735.1 linkc.201_209delTGGCGGCGG p.Gly68_Gly70del disruptive_inframe_deletion Exon 1 of 9 ENSP00000501107.1
HCN1ENST00000634658.1 linkc.201_209delTGGCGGCGG p.Gly68_Gly70del disruptive_inframe_deletion Exon 1 of 2 3 ENSP00000489134.1
HCN1ENST00000638054.1 linkn.-168_-160delTGGCGGCGG upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0284
AC:
4277
AN:
150482
Hom.:
87
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0621
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000398
Gnomad SAS
AF:
0.0207
Gnomad FIN
AF:
0.00774
Gnomad MID
AF:
0.0321
Gnomad NFE
AF:
0.0181
Gnomad OTH
AF:
0.0222
GnomAD2 exomes
AF:
0.0198
AC:
2842
AN:
143504
AF XY:
0.0205
show subpopulations
Gnomad AFR exome
AF:
0.0798
Gnomad AMR exome
AF:
0.0117
Gnomad ASJ exome
AF:
0.00239
Gnomad EAS exome
AF:
0.000429
Gnomad FIN exome
AF:
0.00688
Gnomad NFE exome
AF:
0.0195
Gnomad OTH exome
AF:
0.0200
GnomAD4 exome
AF:
0.0204
AC:
28203
AN:
1379162
Hom.:
534
AF XY:
0.0205
AC XY:
14004
AN XY:
681950
show subpopulations
African (AFR)
AF:
0.0643
AC:
1981
AN:
30824
American (AMR)
AF:
0.0132
AC:
442
AN:
33594
Ashkenazi Jewish (ASJ)
AF:
0.00156
AC:
38
AN:
24366
East Asian (EAS)
AF:
0.000165
AC:
6
AN:
36266
South Asian (SAS)
AF:
0.0289
AC:
2283
AN:
78892
European-Finnish (FIN)
AF:
0.00701
AC:
266
AN:
37968
Middle Eastern (MID)
AF:
0.0288
AC:
147
AN:
5102
European-Non Finnish (NFE)
AF:
0.0203
AC:
21842
AN:
1074886
Other (OTH)
AF:
0.0209
AC:
1198
AN:
57264
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1301
2602
3904
5205
6506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0284
AC:
4280
AN:
150586
Hom.:
87
Cov.:
32
AF XY:
0.0264
AC XY:
1942
AN XY:
73588
show subpopulations
African (AFR)
AF:
0.0619
AC:
2548
AN:
41156
American (AMR)
AF:
0.0166
AC:
251
AN:
15160
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3462
East Asian (EAS)
AF:
0.000399
AC:
2
AN:
5010
South Asian (SAS)
AF:
0.0216
AC:
103
AN:
4772
European-Finnish (FIN)
AF:
0.00774
AC:
80
AN:
10332
Middle Eastern (MID)
AF:
0.0313
AC:
9
AN:
288
European-Non Finnish (NFE)
AF:
0.0181
AC:
1222
AN:
67402
Other (OTH)
AF:
0.0219
AC:
46
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
196
391
587
782
978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00609
Hom.:
5
Asia WGS
AF:
0.0110
AC:
36
AN:
3400

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 02, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 12, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 13, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.4
Mutation Taster
=190/10
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56064803; hg19: chr5-45695986; COSMIC: COSV57500386; COSMIC: COSV57500386; API